Ryan Troup

Ryan Troup is the Editor in Chief of Wealthy VC. Ryan has 15+ years of investing experience. X | Email
Top Stories

Nvidia Reports Strong Q4 Earnings, Beats Analysts’ Expectations on Top and Bottom Lines

The company’s Q4 top and bottom line figures represent a massive increase of 265% and 765% over last year’s fourth…

Read More »
Top Stories

The Winners and Losers of Big Tech’s Earnings Season (VIDEO)

Last Updated: [wpdts-custom start=”post-modified” format=”j.n.Y G:i”] Who were the winners and losers of last week’s big tech earnings season? Let’s…

Read More »
Consumer

ELEVAI Labs Reports Issuance of Patent From U.S. Patent & Trademark Office

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, is pleased to announce that the United States…

Read More »
Tech

2 Stocks Correlated to Donald Trump’s Political Success Jump Up to 239% in Past Week (VIDEO)

With Trump winning decisively again tonight in New Hampshire by double digits, investors should keep an eye on these two…

Read More »
Press Releases

ELEVAI Labs Reports Strong Preliminary Unaudited Financials for Fiscal Year 2023

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced certain preliminary, unaudited management-prepared financial results for…

Read More »
Press Releases

ELEVAI Labs Signs Worldwide License Deal for Proprietary Stem Cell Manufacturing Technology

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce it has signed an…

Read More »
Press Releases

ELEVAI Labs to Participate in Upcoming Aesthetic Industry Conferences

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announces participation in three aesthetic industry conferences in…

Read More »
Top Stories

ELEVAI Labs Posts Q3 2023 Earnings, Reports Record Quarterly Revenue

ELEVAI Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today reported its fiscal 2023 Q3 financial results.…

Read More »
Top Stories

ELEVAI Labs Expands Into European Market With Signing of New Partnership

ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce its new partnership with…

Read More »
Economy

Why the New JOLTS Jobs Data Should Be Music to the Fed’s Ears

The U.S. labor market, which has been out of synch for several years due to the pandemic, appears to be…

Read More »
Back to top button
🔔
Stay Updated!
Get notifications for new content